Huadong Medicine Gross Profit vs. Return On Equity

000963 Stock   35.51  0.44  1.22%   
Based on the measurements of profitability obtained from Huadong Medicine's financial statements, Huadong Medicine Co may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Huadong Medicine's ability to earn profits and add value for shareholders.
 
Gross Profit  
First Reported
2002-06-30
Previous Quarter
3.3 B
Current Value
3.5 B
Quarterly Volatility
1.1 B
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
For Huadong Medicine profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Huadong Medicine to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Huadong Medicine Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Huadong Medicine's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Huadong Medicine Co over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Huadong Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Huadong Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Huadong Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Huadong Medicine Return On Equity vs. Gross Profit Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Huadong Medicine's current stock value. Our valuation model uses many indicators to compare Huadong Medicine value to that of its competitors to determine the firm's financial worth.
Huadong Medicine Co is number one stock in gross profit category among its peers. It also is number one stock in return on equity category among its peers . The ratio of Gross Profit to Return On Equity for Huadong Medicine Co is about  81,382,062,388 . At present, Huadong Medicine's Gross Profit is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Huadong Medicine by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Huadong Medicine's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Huadong Return On Equity vs. Gross Profit

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Huadong Medicine

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
12.03 B
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Huadong Medicine

Return On Equity

 = 

Net Income

Total Equity

 = 
0.15
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Huadong Return On Equity Comparison

Huadong Medicine is currently under evaluation in return on equity category among its peers.

Huadong Medicine Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Huadong Medicine, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Huadong Medicine will eventually generate negative long term returns. The profitability progress is the general direction of Huadong Medicine's change in net profit over the period of time. It can combine multiple indicators of Huadong Medicine, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income3.8 BB
Income Before Tax3.5 B3.6 B
Net Income Applicable To Common Shares2.6 B2.8 B
Net Income2.8 BB
Income Tax Expense562.2 M590.4 M
Net Income From Continuing Ops2.8 B2.5 B
Total Other Income Expense Net-6.4 M-6.7 M
Net Interest Income-46.8 M-49.2 M
Interest Income94 M64 M
Change To Netincome261.1 M142.3 M

Huadong Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Huadong Medicine. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Huadong Medicine position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Huadong Medicine's important profitability drivers and their relationship over time.

Use Huadong Medicine in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Huadong Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Huadong Medicine will appreciate offsetting losses from the drop in the long position's value.

Huadong Medicine Pair Trading

Huadong Medicine Co Pair Trading Analysis

The ability to find closely correlated positions to Huadong Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Huadong Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Huadong Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Huadong Medicine Co to buy it.
The correlation of Huadong Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Huadong Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Huadong Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Huadong Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Huadong Medicine position

In addition to having Huadong Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cryptocurrency Thematic Idea Now

Cryptocurrency
Cryptocurrency Theme
Dynamically computed list of top cryptocurrencies sorted bymarket capitalization. The Cryptocurrency theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Huadong Stock

To fully project Huadong Medicine's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Huadong Medicine at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Huadong Medicine's income statement, its balance sheet, and the statement of cash flows.
Potential Huadong Medicine investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Huadong Medicine investors may work on each financial statement separately, they are all related. The changes in Huadong Medicine's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Huadong Medicine's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.